Follow-on biologics could reduce insulin therapy costs for diabetes patients, but how? This new study reveals.
One theory is that metformin taken during insulin treatment impacts energy intake and so supports weight loss. A quick look at a new study suggests something else.
We do all we can to help patients do all they can to manage their diabetes. We all need to be able to trust the supply chain, from start to finish.
Insulin pump/sensor combos, continuous glucose sensors . . . a wrap-up of these and other advances in endocrinology in 2017, plus some caveats for the future.
Was this pharmacist out of bounds? You make the call.
A top-line look at the latest news: novel risk factors, insulin vs insulin; and predictors of weight loss success.
Five new and upcoming medical devices will help your patients manage their diabetes care.
Our April list includes predictors of fracture risk, endocrine-disrupting chemicals, and CV effects of thyroid dysfunction.
A study compared mortality and major adverse cardiovascular events in patients with type 2 diabetes prescribed metformin or insulin.
Three studies from ENDO 2017 focused on improving patient care through brain stimulation, an artificial pancreas system, and videoconferencing.